Related Experiment Videos
Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1
Abstract:
In cultured astrocytes, all three major transcripts of beta-amyloid precursor protein (APP) were expressed with the ratio for APP695, APP751 and APP770 isoform mRNAs being 1:4:2. In comparison with controls, treatment of astrocytes with transforming growth factor-beta 1 (TGF-beta 1) produced about 6 fold increase in total APP mRNA, while elevation in the interleukin-1 beta (IL-1 beta) treated group was small and may relate to the mitogenic effect of IL-1 beta on astrocytes. Treatment of astrocytes with cytokines also produced marked changes in the upregulation in expression of different APP isoforms. The net increase in mRNAs of KPI-containing isoforms APP751 and APP770 was relatively more than for the APP695 isoform. This phenomenon was mainly related to the differences in the expression of KPI-containing APP isoforms and APP695 isoform in the controls. The present findings provide further evidence for the involvement of astrocytes in a cascade of events leading to the development of senile plaques in Alzheimer's disease and Down's syndrome.
Insights
Transforming growth factor-beta 1 (TGF-beta 1) significantly increases beta-amyloid precursor protein (APP) mRNA in astrocytes. This suggests astrocytes play a role in Alzheimer's disease and Down syndrome pathology.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Astrocytes express three major beta-amyloid precursor protein (APP) transcripts: APP695, APP751, and APP770.
- The baseline expression ratio of these isoforms is approximately 1:4:2.
- APP is implicated in the pathogenesis of Alzheimer's disease and Down syndrome.
Purpose of the Study:
- To investigate the effect of cytokines, specifically transforming growth factor-beta 1 (TGF-beta 1) and interleukin-1 beta (IL-1 beta), on APP mRNA expression in cultured astrocytes.
- To determine how these cytokines influence the expression of different APP isoforms.
- To elucidate the role of astrocytes in the development of senile plaques associated with neurodegenerative diseases.
Main Methods:
- Cultured astrocytes were treated with TGF-beta 1 and IL-1 beta.
- Quantitative analysis of total APP mRNA and specific APP isoform mRNA levels was performed using techniques such as Northern blotting or RT-PCR (implied).
- Comparison of gene expression levels between cytokine-treated groups and control groups.
Main Results:
- Treatment with TGF-beta 1 resulted in a significant, approximately 6-fold increase in total APP mRNA levels in astrocytes.
- IL-1 beta treatment showed a smaller increase in total APP mRNA, potentially due to its mitogenic effects on astrocytes.
- Cytokine treatment led to differential upregulation of APP isoforms, with a more pronounced increase in KPI-containing isoforms (APP751 and APP770) compared to APP695.
Conclusions:
- Astrocytes are responsive to inflammatory cytokines like TGF-beta 1, which can significantly alter APP mRNA expression.
- The differential regulation of APP isoforms suggests a complex cellular response to cytokine signaling.
- These findings support the involvement of astrocytes in the molecular cascade leading to amyloid plaque formation in Alzheimer's disease and Down syndrome.